S2E14 - Oral contraception and thrombotic risk
Presented by Audrey Carlo and Cécile Hourquet // Special guest Laure Morimont, Project leader at QUALIblood SA
Welcome to Ask Stago, the podcast dedicated to provide expert answers to your expert questions in hemostasis.
In today episode, our expert guest, Laure Morimont, Project leader at QUALIblood SA, will detail with us the current knowledge on thrombotic risk under hormonal therapy and how this can be assessed.
As usual, don’t forget to send any question you may have to ask@stago.com, we will be glad to answer to it.
Learn more ⬇️
Literature sources:
-
de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD010813. DOI: 10.1002/14651858.CD010813.pub2. Accessed 16 June 2021.
-
Douxfils J, Morimont L, Bouvy C. Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk. Semin Thromb Hemost. 2020 Nov;46(8):872-886. doi: 10.1055/s-0040-1714140. Epub 2020 Oct 20. PMID: 33080636.
-
Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: A bench to bedside review. Thromb Res. 2020 Aug;192:40-51. doi: 10.1016/j.thromres.2020.05.008. Epub 2020 May 11. PMID: 32450447; PMCID: PMC7341440.
-
Morimont L, Dogné JM, Douxfils J. Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled "Estrogen and thrombosis: A bench to bedside review" (Thrombosis Research 192 (2020) 40-51). Thromb Res. 2020 Sep;193:221-223. doi: 10.1016/j.thromres.2020.08.006. Epub 2020 Aug 5. PMID: 32798963.
Visit QUALIblood website: https://www.qualiblood.eu
Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.
Welcome to Ask Stago, the podcast dedicated to provide expert answers to your expert questions in hemostasis.
In today episode, our expert guest, Laure Morimont, Project leader at QUALIblood SA, will detail with us the current knowledge on thrombotic risk under hormonal therapy and how this can be assessed.
As usual, don’t forget to send any question you may have to ask@stago.com, we will be glad to answer to it.
Learn more ⬇️
Literature sources:
- de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD010813. DOI: 10.1002/14651858.CD010813.pub2. Accessed 16 June 2021.
- Douxfils J, Morimont L, Bouvy C. Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk. Semin Thromb Hemost. 2020 Nov;46(8):872-886. doi: 10.1055/s-0040-1714140. Epub 2020 Oct 20. PMID: 33080636.
- Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: A bench to bedside review. Thromb Res. 2020 Aug;192:40-51. doi: 10.1016/j.thromres.2020.05.008. Epub 2020 May 11. PMID: 32450447; PMCID: PMC7341440.
- Morimont L, Dogné JM, Douxfils J. Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled "Estrogen and thrombosis: A bench to bedside review" (Thrombosis Research 192 (2020) 40-51). Thromb Res. 2020 Sep;193:221-223. doi: 10.1016/j.thromres.2020.08.006. Epub 2020 Aug 5. PMID: 32798963.
Visit QUALIblood website: https://www.qualiblood.eu
Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.
- coagulation
- hemostasis
- thrombosis
- hormones
- oral contraception
- ask stago
- risk management
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.